Pharmaceutical Technology

AUGUST 22, 2022

When it comes to pharmaceutical, nutritional or cosmeceutical dosing, some of the most crucial parameters are safety, product effectiveness and patient adherence. Softgels have now achieved strong recognition in the prescription, consumer health and supplements markets. billion by 2028, at a CAGR of 12.6%.

Prescription 52

Prescription Safety Patients Pharmaceutical 52

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

PM360

SEPTEMBER 21, 2023

Under the pathway, manufacturers can use safety and efficacy data from existing products in their applications for their own products. This product would be a more potent prescription version than the OTCs, Casberg notes. This pathway is being used to produce more naloxone products, which reverse opioid overdoses.

Management 105

Management Manufacturing Sales Competition 105

Pharmaceutical Representative Training

JANUARY 29, 2025

These high prices are the result of multiple factors: theyre derived from living organisms making them sensitive and complex for both manufacturers and patients, research requires advanced technology to test for safety and effectiveness, and theyre in high demand without much competition. The Cost-Saving Alternative: What are Biosimilars?

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Clarivate

MAY 13, 2024

Many insurers use similar networks for Medicaid and exchange plans, so shifting to an exchange plan is less likely to cause a lapse in coverage or abandonment of prescription drugs or maintenance medications that control chronic conditions.

Insurance 52

Insurance Marketing Healthcare Healthcare 52